The case of eculizumab: litigation and purchases by the Brazilian Ministry of Health

OBJECTIVES: This study examined the purchases of eculizumab, a high-cost monoclonal antibody used in the treatment of rare diseases by Brazilian federal agencies, in terms of purchased quantities, expenditures, and prices. METHODS: Eculizumab purchases made between March 2007 and December 2018 were...

Descripción completa

Detalles Bibliográficos
Autores principales: Caetano, Rosângela, Rodrigues, Paulo Henrique Almeida, Corrêa, Marilena C Villela, Villardi, Pedro, Osorio-de-Castro, Claudia Garcia Serpa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculdade de Saúde Pública da Universidade de São Paulo 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017980/
https://www.ncbi.nlm.nih.gov/pubmed/32130309
http://dx.doi.org/10.11606/s1518-8787.2020054001693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017980/
https://www.ncbi.nlm.nih.gov/pubmed/32130309
http://dx.doi.org/10.11606/s1518-8787.2020054001693

Ejemplares similares